Skip to main content
. 2016 Aug 18;7:262. doi: 10.3389/fphar.2016.00262

Table 1.

Parameters derived from non-linear (G, P1, P2, HR range, G, and BP50) and linear (slope bradycardia and slope tachycardia) regression analysis of the baroreflex in animals treated with vehicle or losartan and subjected to RRS or CVS.

Group G (bpm/mmHg) P1 (Δbpm) P2 (Δbpm) HR range (bpm) BP50 (ΔmmHg) Slope Bradycardia (bpm/mmHg) Slope Tachycardia (bpm/mmHg)
Vehicle
Control -2.1 ± 0.2 -74 ± 5 134 ± 8 202 ± 6 -1.3 ± 5 -2.3 ± 0.2 -3.2 ± 0.5
RRS -1.2 ± 0.2 -59 ± 6 94 ± 8 157 ± 5 -4.2 ± 4 -1.7 ± 0.2 -2.6 ± 0.4
CVS -1.2 ± 0.2 -66 ± 6 96 ± 9 164 ± 12 -2.1 ± 3 -2.4 ± 0.3 -2.5 ± 0.5
Losartan
Control -2.3 ± 0.3 -78 ± 9 109 ± 12 187 ± 11 1.0 ± 3 -1.9 ± 0.3 -2.7 ± 0.6
RRS -2.6 ± 0.2# -89 ± 9 102 ± 11 199 ± 8# 0.0 ± 2 -2.6 ± 0.4 -2.0 ± 0.6
CVS -1.8 ± 0.2# -66 ± 9 115 ± 12 178 ± 18 -5.4 ± 2 -2.3 ± 0.3 -3.0 ± 0.5

Values are mean ± SEM (n = 6: vehicle control, losartan control; n = 7: losartan CVS; n = 8: vehicle RRS, vehicle CVS, losartan RRS).

P < 0.05 versus control group within same condition, #P < 0.05 versus respective group vehicle. Two-way ANOVA followed by Bonferroni’s post hoc test.